Literature DB >> 31823341

The other view: the trace element selenium as a micronutrient in thyroid disease, diabetes, and beyond.

Lutz Schomburg1,2,3,4.   

Abstract

Antibiotics are provided for infections caused by bacteria, and statins help to control hypercholesterolemia. When hungry, you need to eat, and when you are deficient in a particular nutrient, the diet should be chosen wisely to provide what is missing. In the matter of providing the essential trace element selenium (Se), there are two different but partly overlapping views on its nature and requirements. Some consider it a medication that should be given to a subset of more or less well-defined (thyroid) patients only, in order to alleviate symptoms, to improve the course of the disease or even to provide a cure, alone or in an adjuvant mode. Such treatment attempts are conducted for a short time period, and potential medical benefits and side effects are evaluated thoroughly. One could also approach Se in medicine in a more holistic way and evaluate primarily the nutritional status of the patient before considering supplementation. The available evidence for positive health effects of supplemental Se can be interpreted as the consequence of correcting deficiency instead of speculating on a direct pharmaceutical action. This short review provides a novel view on Se in (thyroid) disease and beyond and offers an alternative explanation for its positive health effects, i.e., its provision of the substrate needed for allowing adequate endogenous expression of those selenoproteins that are required in certain conditions. In Se deficiency, the lack of the trace element constitutes the main limitation for the required adaptation of selenoprotein expression to counteract health risks and alleviate disease symptoms. Supplemental Se lifts this restriction and enables the full endogenous response of selenoprotein expression. However, since Se does not act as a pharmacological medication per se, it should not be viewed as a dangerous drug, and, importantly, current data show that supplemental Se does not cause diabetes.

Entities:  

Keywords:  Cancer; Cardiovascular disease; Deficiency; Diabetes; Micronutrient; Prevention; Selenoprotein; Substitution; Supplementation; Treatment

Year:  2019        PMID: 31823341     DOI: 10.1007/s42000-019-00150-4

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  22 in total

1.  Vitamin and Mineral Status in a Vegan Diet.

Authors:  Cornelia Weikert; Iris Trefflich; Juliane Menzel; Rima Obeid; Alessa Longree; Jutta Dierkes; Klaus Meyer; Isabelle Herter-Aeberli; Knut Mai; Gabriele I Stangl; Sandra M Müller; Tanja Schwerdtle; Alfonso Lampen; Klaus Abraham
Journal:  Dtsch Arztebl Int       Date:  2020-08-31       Impact factor: 5.594

2.  Selenium Status in Paediatric Patients with Neurodevelopmental Diseases.

Authors:  Christian L Görlich; Qian Sun; Viola Roggenkamp; Julian Hackler; Sebastian Mehl; Waldemar B Minich; Angela M Kaindl; Lutz Schomburg
Journal:  Nutrients       Date:  2022-06-08       Impact factor: 6.706

Review 3.  Ferroptosis and Its Potential Role in Metabolic Diseases: A Curse or Revitalization?

Authors:  Jia-Yue Duan; Xiao Lin; Feng Xu; Su-Kang Shan; Bei Guo; Fu-Xing-Zi Li; Yi Wang; Ming-Hui Zheng; Qiu-Shuang Xu; Li-Min Lei; Wen-Lu Ou-Yang; Yun-Yun Wu; Ke-Xin Tang; Ling-Qing Yuan
Journal:  Front Cell Dev Biol       Date:  2021-07-09

Review 4.  Toxicology and pharmacology of synthetic organoselenium compounds: an update.

Authors:  Cristina W Nogueira; Nilda V Barbosa; João B T Rocha
Journal:  Arch Toxicol       Date:  2021-04-01       Impact factor: 6.168

5.  Selenium and Copper as Biomarkers for Pulmonary Arterial Hypertension in Systemic Sclerosis.

Authors:  Qian Sun; Julian Hackler; Julia Hilger; Hans Gluschke; Aldina Muric; Szandor Simmons; Lutz Schomburg; Elise Siegert
Journal:  Nutrients       Date:  2020-06-25       Impact factor: 5.717

6.  Selenium Deficiency Is Associated with Mortality Risk from COVID-19.

Authors:  Arash Moghaddam; Raban Arved Heller; Qian Sun; Julian Seelig; Asan Cherkezov; Linda Seibert; Julian Hackler; Petra Seemann; Joachim Diegmann; Maximilian Pilz; Manuel Bachmann; Waldemar B Minich; Lutz Schomburg
Journal:  Nutrients       Date:  2020-07-16       Impact factor: 5.717

7.  LRRC19-A Bridge between Selenium Adjuvant Therapy and Renal Clear Cell Carcinoma: A Study Based on Datamining.

Authors:  Yitong Zhang; Jiaxing Wang; Xiqing Liu
Journal:  Genes (Basel)       Date:  2020-04-17       Impact factor: 4.096

Review 8.  Fetal Programming Is Deeply Related to Maternal Selenium Status and Oxidative Balance; Experimental Offspring Health Repercussions.

Authors:  María Luisa Ojeda; Fátima Nogales; Inés Romero-Herrera; Olimpia Carreras
Journal:  Nutrients       Date:  2021-06-18       Impact factor: 5.717

9.  Relation of Serum Copper Status to Survival in COVID-19.

Authors:  Julian Hackler; Raban Arved Heller; Qian Sun; Marco Schwarzer; Joachim Diegmann; Manuel Bachmann; Arash Moghaddam; Lutz Schomburg
Journal:  Nutrients       Date:  2021-05-31       Impact factor: 5.717

10.  Selenoprotein P as Biomarker of Selenium Status in Clinical Trials with Therapeutic Dosages of Selenite.

Authors:  Ola Brodin; Julian Hackler; Sougat Misra; Sebastian Wendt; Qian Sun; Elena Laaf; Christian Stoppe; Mikael Björnstedt; Lutz Schomburg
Journal:  Nutrients       Date:  2020-04-12       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.